Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 17, 2021 | SVP Global Operations and R&D | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 294 | $24.76 | 18,181 | |
| Jul 17, 2021 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 354 | $24.76 | 61,653 | |
| Jul 18, 2021 | SVP/GM, Vascular Access | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 300 | $24.76 | 22,591 | |
| Jul 18, 2021 | SVP/GM, VIT | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 344 | $24.76 | 43,821 | |
| Jul 18, 2021 | Director, President and CEO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,483 | $24.76 | 335,083 | |
| Jul 18, 2021 | SVP Global Operations and R&D | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 417 | $24.76 | 17,764 | |
| Jul 18, 2021 | EVP and CFO | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 400 | $24.76 | 61,253 | |
| Jul 21, 2021 | Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,738 | -- | 42,401 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,388 | -- | 26,979 | |
| Jul 21, 2021 | SVP/GM, Vascular Access | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,777 | -- | 8,777 |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.